Professional Documents
Culture Documents
ABSTRACT
Two simple, accurate, precise, reproducible, requiring no prior separation and economical procedures
for simultaneous estimation of guaifenesin and pseudoephedrine hydrochloride in tablet dosage form
have been developed. First method is simultaneous equation method; in this method 272 nm and 257
nm were selected to measure the absorbance of guaifenesin and pseudoephedrine hydrochloride
respectively. The second method is Q‐value analysis based on measurement of absorptivity at 265.50
nm (as an iso‐absorptive point) and 272 nm. guaifenesin and pseudoephedrine hydrochloride at their
respective maximum wavelength 272 nm and 257 nm and at isoabsorptive point 265.50 nm shows
linearity in a concentration range of 30-150 µg/mL and 300-1500 µg/mL respectively. Recovery
studies range from >98.50% for guaifenesin and >98.90% for pseudoephedrine hydrochloride in case
of simultaneous equation method and >98.24% for guaifenesin and >98.09% for pseudoephedrine
hydrochloride in case of Q‐analysis method confirming the accuracy of the proposed method. The
proposed methods are recommended for routine analysis since it is rapid, simple, accurate and also
sensitive and specific (no heating and no organic solvent extraction is required).
KEYWORDS
Guaifenesin, Pseudoephedrine hydrochloride, Simultaneous equation method, Q analysis.
*Corresponding Author:
Rahul sahu
Sagar Institute of Research and Technology-Pharmacy,
Ayodhya bypass Road, Bhopal (M.P.) – 462041(India).
Email: rhulsahu@gmail.com
Contact no. +919039531653
OH
H 2N
O H
.HCl
O OH
H OH
A B
Fig 1: (A) Structure of Guaifenesin, (B) Structure of Pseudoephedrine hydrochloride.
Various spectrophotometric6-8, HPLC9, 10
, Electrokinetic chromatography11, Voltammetric assay12,
Capillary gas chromatography13 and ion pair high performance liquid chromatography14 methods are
also reported in the literature for the estimation of Guaifenesin and Pseudoephedrine individually and
in combination with other drugs. According to literature survey no UV method has yet been reported
for simultaneous estimation of guaifenesin and pseudoephedrine hydrochloride in tablet dosage forms.
Hence, an attempt has been made to develop and validate in accordance with ICH guidelines. 4, 5
INSTRUMENTATION
A double beam UV-visible spectrophotometer (SHIMADZU, Japan), model UV-1700 PC was used.
The software employed was UV probe version 2.33. The spectra was recorded over
range 200-400nm against solvent in 1 cm quarts cells.
Where A1 and A2 are absorbance of mixture at 272 nm and 257 nm respectively, ax1 and ax2 are
absorptivities of pseudoephedrine hydrochloride at λ1 and λ2 respectively and ay1 and ay2 are
absorptivities of guaifenesin at at λ1 and λ2 respectively. Cx and Cy are concentration of
pseudoephedrine hydrochloride and guaifenesin respectively.
Where, A1 and A2 are the absorbances of mixture at 265.50 nm and 272 nm and ax1, ax2 and ay1, ay2
are absorptivities E (1%, 1 cm) of pseudoephedrine hydrochloride and guaifenesin at 265.50 nm and
272 nm and Qm= A2/A1, Qy = ay2/ay1 and Qx = ax2/ax1.
LINEARITY
The proposed method was found to be linear in the range of 30-150µg/ml and 300-1500µg/ml with
correlation coefficient 0.9997 and 0.9998 for guaifenesin (GUA) and pseudoephedrine hydrochloride
(PSE) respectively. Result of linearity study shown in Table 1.
TABLE 1: RESULTS OF LINEARITY
Method - I Method-II
Parameters
GUA PSE GUA PSE
Working λ 272 nm 257 nm 272 nm 265.50nm
Beer's law limit (µg/ml) 30-150 300-1500 30-150 300-1500
Correlation Coefficient (r2)* 0.9997 0.9998 0.9997 0.9998
Slope (m)* 0.044 0.006 0.035 0.006
Intercept (c)* 0.001 0.002 -0.001 0.002
* Average of five determination
RECOVERY STUDIES
TABLE 2: RESULTS OF RECOVERY STUDIES
Recovery
% Recovery (Mean ±SD)*
Level%
Method - I Method-II
GUA PSE GUA PSE
80 96.70±0.20 99.10±0.17 98.50±0.06 97.59±0.35
100 98.50±0.06 98.90±0.23 98.24±0.09 98.09±0.27
120 99.70±0.05 98.40±0.21 95.98±0.06 98.48±0.50
*Average of nine determinations
PRECISION
The results of the repeatability and intermediate precision experiments are shown in (Table 3, 4). The
developed method was found to be precise as the RSD values for repeatability and intermediate
precision studies were < 2 %, respectively as recommended by ICH guidelines.
ANALYSIS OF A FORMULATION
Experimental results show that there is no interference from any of the excipients which are normally
present with that of standard guaifenesin and pseudoephedrine hydrochloride. The drug content was
found to be close to 100 for guaifenesin and for pseudoephedrine hydrochloride (Table 5).
CONCLUSIONS
The simultaneous UV method was developed and validated for simultaneous estimation of Guaifenesin
and Pseudoephedrine hydrochloride in tablet dosage form. Proposed method is fast, accurate, precise
and sensitive hence it can be employed for routine quality control of tablets containing both drugs in
industries.
REFERENCES
1. Indian Pharmacopoeia. Indian pharmacopoeia commission, Ghaziabad; 2007: 558-559, 1005-1006.
2. British Pharmacopoeia. British pharmacopoeia commission London; 2009: 2861, 5094.
3. Laurence LB, “Pulmonary Pharmacology”. Goodman and Gilman. The pharmacological basis of
therapeutics. 11th ed. McGraw-Hill: New York; 2006: 832-836.
4. Code Q2A-Text on Validation of Analytical Procedure Step-3 Consensus Guideline. ICH
Harmonised Tripartite Guideline; 1994.
5. Code Q2B- Validation of Analytical Procedure Methodology Step-4 Consensus Guideline. ICH
Harmonised Tripartite Guideline; 1994.
6. Prasanthi NL, Mohan Krishana C, Manikiran SS, Rao N R. Estimation of ambroxol hydrochloride
and guiaphensin in tablet dosage form by simultaneous equation method. IJRAP 2010; 1: 140-146.